- £144.29m
- £116.11m
- £36.04m
- 98
- 19
- 77
- 74
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 22.9 | 25.1 | 27.2 | 30.5 | 36 |
Cost of Revenue | |||||
Gross Profit | 20.6 | 22.2 | 24.5 | 25.4 | 30.3 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 21.4 | 23.9 | 25.4 | 27.3 | 32.2 |
Operating Profit | 1.5 | 1.23 | 1.75 | 3.19 | 3.81 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.752 | 0.497 | 0.985 | 2.31 | 4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.61 | 0.487 | 0.974 | 2.4 | 4.21 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.61 | 0.487 | 0.974 | 2.4 | 4.21 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 0.61 | 0.487 | 0.974 | 2.4 | 4.21 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.001 | 0.004 | 0.009 | 0.015 | 0.027 |
Dividends per Share |